DUBLIN--(BUSINESS WIRE)--Jun. 8, 2017--
Alkermes
plc (NASDAQ: ALKS) announced today that its Chief Executive Officer,
Richard Pops, will participate in a fireside chat at the Goldman Sachs 38th
Annual Global Healthcare Conference on Thursday, June 15, 2017 at 8:40
a.m. PT (11:40 a.m. ET/4:40 p.m. BST) from Rancho Palos Verdes, Calif.
The audio portion of the fireside chat may be accessed under the
Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170608005887/en/
Source: Alkermes plc
Alkermes plc
Jennifer Zibuda, +1 781-609-6129
Corporate
Communications
